Status:
RECRUITING
Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Radiation Treatment
Neurovascular Complications
Eligibility:
All Genders
20-100 years
Brief Summary
Head and neck cancer is a group of cancers develop from the soft tissues, salivary gland, mucosa of the upper respiratory or digestive system covering the oral and nasal cavity. Radiotherapy is usuall...
Eligibility Criteria
Inclusion
- Population: Prospective cohort
- Age ≥20 years.
- Head and neck cancer patient .
- Had ever received radiation therapy (RT) ≦ 72 months before inclusion in the registry.
- Had ≥ 1 brain images and cervical-cranial vascular studies between the end of RT and d date of enrolment.
Exclusion
- Age \<20 years.
- Patients not willing to sign the informed consent.
- Population: Retrospective validation cohort
- Inclusion Criteria:
- Age ≥20 years.
- Head and neck cancer patient.
- Had ever received radiation therapy (RT) \> 120 months before the adoption date of IRB at the participant site.
- Had ≥ 2 brain images and cervical-cranial vascular studies between the end of RT and 6\~10 years after RT, one within 5 years after RT, the other after 5 years after RT.
Key Trial Info
Start Date :
April 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 10 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06111430
Start Date
April 11 2022
End Date
April 10 2026
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taipei, Taiwan